Drug Price Negotiations with Michael Cannon of the CATO Institute

Michael Cannon is Director of Health Policy Studies at the Cato Institute. We're going to discuss the lawsuit by pharmaceutical giant Merck against the federal government's scheme to require drug companies to negotiate certain prices for drugs used by Medicare participants. Merck calls it a "sham".

https://www.cato.org/people/michael-f-cannon

Merck sues Biden administration over Medicare drug price negotiations

Merck & Co. Sues HHS over 'Sham' Drug Price Negotiation Program | National Review